Per Anders Göte Samuelsson

Biography

  Mr. Per Anders Göte Samuelsson, M.Sc., is a Partner at HealthCap. He joined HealthCap in 2000. He served as a Director of Corporate Finance Department at ABB Aros Securities where he specialized in the areas of Merger Transactions, Initial Public Offerings and Equity Incentive Programs. He served the Head of Research at ABB Aros Securities. He served as Key Account Manager of PartnerTech AB (publ). He served as a Director of Corporate Finance at Nordea Securities AB. He serves as Chairman of The Board at Oncos Therapeutics Ltd. He has been a Director of Oncopeptides AB since 2012, Nordic Nanovector ASA since November 2014, Targovax ASA since September 2015 and Algeta ASA since September 29, 2005. Mr. Samuelsson serves as Director of Millicore AB, BioStratum Incorporated, Optivy AB, Nucleonics, Inc., SwedenBIO Service AB and Cardoz AB. He served as Director of Onxeo SA until November 07, 2014. He served as Director TopoTarget A/S since July 2009. He served as Director of Sopherion Therapeutics, LLC and Carmeda AB. Mr. Samuelsson has over 15 years of investment banking experience specializing in the areas of Merger Transactions, Initial Public Offerings and Equity Incentive Programs. Mr. Samuelsson received an M.Sc. in Engineering from the Institute of Technology in Linköping.

Research Interest

Engineering